What’s wrong with this picture?

Picture 1:

Nothing if you think that a small town, intellectually inclined, Ivy League graduate, Rhodes scholar who speaks Norwegian has a better grasp of women’s’ issues than someone like, oh, I don’t know, Elizabeth Warren, Kamala Harris or Kirsten Gillibrand.

Hey, remember when Ms. Magazine made Obama Feminist of the Year or some other self discrediting proclamation. And then he touted Lily Ledbetter for 8 years but did squat on Paycheck Fairness, and on top of that made sure Plan B wasn’t sold OTC to anyone under 18 because he didn’t want his daughters to be able to get it without him knowing about it?

Good times, good times.

Picture 2:

I’ve got a newfangled gizmo on my arm. It’s part of my protocol that started yesterday. (So far, so good, guys. Everything going well. No worries, be happy).

So anyway, this is an autoinjector that is going to beep at the same frequency as my tinnitus in about 7 hours from now and then inject me with something. No, I’m sure it won’t come as a surprise.

Up until 2015, this gizmo cost about $6000.00.

After 2015, it shot up to $17000.00.

So this is the most expensive thing I’ve ever had on my body.

It flashes green at night. I look like a firefly.

Very pretty.

Unnecessarily expensive.

Clarification: As a former pharma R&D researcher, I know that research is expensive. But the drastic price increase on this gizmo was purely a financial one by the MBAs that now run the companies. They rip up the portfolios, lay the researchers off and makes sure shareholders get their value. R&D, who is always taking the brunt of cost savings measures, has nothing to do with the price increase.